Cite
HARVARD Citation
Crépin, R. et al. (2017). Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenografts. Pigment cell & melanoma research. pp. 317-327. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Crépin, R. et al. (2017). Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenografts. Pigment cell & melanoma research. pp. 317-327. [Online].